Ting Su

997 total citations · 1 hit paper
21 papers, 784 citations indexed

About

Ting Su is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ting Su has authored 21 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Ting Su's work include Immunotherapy and Immune Responses (7 papers), RNA Interference and Gene Delivery (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Ting Su is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), RNA Interference and Gene Delivery (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Ting Su collaborates with scholars based in China, United States and Netherlands. Ting Su's co-authors include Guizhi Zhu, Shuibin Lin, Furong Cheng, Yu Zhang, Kristoffer Valerie, Xiang‐Yang Wang, Shurong Zhou, Fuwu Zhang, Long Jiang Zhang and Qianqian Ni and has published in prestigious journals such as Accounts of Chemical Research, ACS Nano and Scientific Reports.

In The Last Decade

Ting Su

19 papers receiving 776 citations

Hit Papers

Small circular RNAs as vaccines for cancer immunotherapy 2025 2026 2025 5 10 15 20

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ting Su China 11 530 324 270 185 109 21 784
Lauren E. Milling United States 9 485 0.9× 257 0.8× 263 1.0× 238 1.3× 144 1.3× 11 787
Marisa Aikins United States 10 296 0.6× 282 0.9× 253 0.9× 124 0.7× 119 1.1× 10 646
Xiaoyue Shi China 6 421 0.8× 275 0.8× 363 1.3× 114 0.6× 113 1.0× 14 829
Karthik Tiruthani United States 11 314 0.6× 295 0.9× 228 0.8× 279 1.5× 94 0.9× 17 746
Yonger Xue United States 15 250 0.5× 573 1.8× 235 0.9× 137 0.7× 167 1.5× 25 954
Laura Jeanbart Switzerland 9 654 1.2× 399 1.2× 265 1.0× 372 2.0× 87 0.8× 10 1.0k
Matthew Lin United States 6 524 1.0× 340 1.0× 288 1.1× 387 2.1× 101 0.9× 10 899
Coralie M. Backlund United States 13 309 0.6× 329 1.0× 132 0.5× 199 1.1× 84 0.8× 18 663

Countries citing papers authored by Ting Su

Since Specialization
Citations

This map shows the geographic impact of Ting Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Su more than expected).

Fields of papers citing papers by Ting Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Su. The network helps show where Ting Su may publish in the future.

Co-authorship network of co-authors of Ting Su

This figure shows the co-authorship network connecting the top 25 collaborators of Ting Su. A scholar is included among the top collaborators of Ting Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting Su. Ting Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Long, Fengshuo Wang, Yue Liu, et al.. (2025). ROS/NO dual-releasing organic polymer nanoenzymes for NIR-II photo-adjuvant cancer immunotherapy. Nano Today. 67. 102936–102936.
2.
Zhou, Shurong, Yuqing Liang, Yu Hao, et al.. (2025). Combined cancer immunotherapy with lipid nanoparticle delivery of oligo-based cGAS-agonistic adjuvant and peptide or mRNA vaccines. Molecular Therapy — Nucleic Acids. 36(3). 102623–102623. 2 indexed citations
3.
Su, Ting, Jun Wu, Xiang Yu, et al.. (2025). Drug functional remapping: a new promise for tumor immunotherapy. Frontiers in Oncology. 15. 1519355–1519355. 1 indexed citations
4.
Yan, Ting, et al.. (2025). Oxidative stress gene expression in ulcerative colitis: implications for colon cancer biomarker discovery. Scientific Reports. 15(1). 22641–22641.
5.
Zhang, Yu, Xiang Liu, Tingting Shen, et al.. (2025). Small circular RNAs as vaccines for cancer immunotherapy. Nature Biomedical Engineering. 9(2). 249–267. 23 indexed citations breakdown →
6.
Li, Meng, Zichao Li, Wenzhi Tu, et al.. (2025). X-ray-Responsive Semiconducting Polymer siRNA Nanosystems for Orthotopic Glioma Treatment via Silencing the Immunosuppressive Signal. ACS Nano. 19(18). 17247–17260. 2 indexed citations
7.
Zhou, Shurong, Ting Su, Furong Cheng, et al.. (2024). Engineering cGAS-agonistic oligonucleotides as therapeutics for cancer immunotherapy. Molecular Therapy — Nucleic Acids. 35(1). 102126–102126. 8 indexed citations
8.
Jiang, Tiantian, et al.. (2024). Biomimetic Cell Membrane‐Coated Nanoparticles for Cancer Theranostics. ChemMedChem. 19(22). 11 indexed citations
9.
Su, Ting, Shurong Zhou, Xuwen Liu, et al.. (2023). Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect. Science Advances. 9(28). eade6257–eade6257. 52 indexed citations
10.
Cheng, Furong, Ting Su, Shurong Zhou, et al.. (2023). Targeting Lymph Nodes for Systemic Immunosuppression Using Cell‐Free‐DNA‐Scavenging And cGAS‐Inhibiting Nanomedicine‐In‐Hydrogel for Rheumatoid Arthritis Immunotherapy. Advanced Science. 10(26). e2302575–e2302575. 38 indexed citations
11.
Su, Ting, Shurong Zhou, Fuwu Zhang, et al.. (2023). Lymph node-targeting adjuvant/neoantigen-codelivering vaccines for combination glioblastoma radioimmunotherapy. Theranostics. 13(13). 4304–4315. 2 indexed citations
12.
Su, Ting, Xiang Liu, Shuibin Lin, Furong Cheng, & Guizhi Zhu. (2023). Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapy. Bioactive Materials. 26. 169–180. 26 indexed citations
13.
Zhou, Shurong, et al.. (2023). Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases. Accounts of Chemical Research. 56(21). 2933–2943. 48 indexed citations
14.
Su, Ting, Furong Cheng, Jialong Qi, et al.. (2022). Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy. Advanced Science. 9(23). e2201895–e2201895. 65 indexed citations
15.
Su, Ting, Furong Cheng, Yuji Pu, et al.. (2021). Polymeric micelles amplify tumor oxidative stresses through combining PDT and glutathione depletion for synergistic cancer chemotherapy. Chemical Engineering Journal. 411. 128561–128561. 47 indexed citations
16.
Ni, Qianqian, Fuwu Zhang, Yijing Liu, et al.. (2020). A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer. Science Advances. 6(12). eaaw6071–eaaw6071. 223 indexed citations
17.
Cheng, Furong, Ting Su, Kui Luo, Yuji Pu, & Bin He. (2019). The polymerization kinetics, oxidation-responsiveness, and in vitro anticancer efficacy of poly(ester-thioether)s. Journal of Materials Chemistry B. 7(6). 1005–1016. 23 indexed citations
18.
Su, Ting, Yu Zhang, Kristoffer Valerie, et al.. (2019). STING activation in cancer immunotherapy. Theranostics. 9(25). 7759–7771. 192 indexed citations
19.
Zhang, Lei, Chen Liu, Mei Yuan, et al.. (2019). Piperlongumine produces antidepressant-like effects in rats exposed to chronic unpredictable stress. Behavioural Pharmacology. 30(8). 721–728. 6 indexed citations
20.
Cheng, Furong, Ting Su, Yuji Pu, Wenxia Gao, & Bin He. (2019). Polymer Structure‐Guided Self‐Assisted Preparation of Poly(ester‐thioether)‐Based Hollow Porous Microspheres and Hierarchically Interconnected Microcages for Drug Release. Macromolecular Bioscience. 19(10). e1900171–e1900171. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026